BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37331230)

  • 1. Value of integrated pulmonary index to predict exacerbation of chronic obstructive pulmonary Disease's severity.
    Karaarslan FN; Öztürk ZS; Işık GÇ; Çevik Y
    Am J Emerg Med; 2023 Sep; 71():54-58. PubMed ID: 37331230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E; Chang CL; Hancox RJ
    Clin Respir J; 2018 Dec; 12(12):2668-2675. PubMed ID: 30471191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR.
    Gayaf M; Karadeniz G; Güldaval F; Polat G; Türk M
    Expert Rev Respir Med; 2021 Jun; 15(6):845-851. PubMed ID: 33691562
    [No Abstract]   [Full Text] [Related]  

  • 4. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease.
    Steer J; Gibson J; Bourke SC
    Thorax; 2012 Nov; 67(11):970-6. PubMed ID: 22895999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Huang Q; He C; Xiong H; Shuai T; Zhang C; Zhang M; Wang Y; Zhu L; Lu J; Jian L
    BMJ Open; 2020 Oct; 10(10):e037923. PubMed ID: 33127631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation Score and BAP-65 Score, Tools for Prediction of Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Comparative Pilot Study.
    Sangwan V; Chaudhry D; Malik R
    Indian J Crit Care Med; 2017 Oct; 21(10):671-677. PubMed ID: 29142379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation.
    Shi QF; Sheng Y; Zhu N; Tan Y; Xie XH; Wang SY; Cai JF
    Clin Respir J; 2019 Jul; 13(7):438-445. PubMed ID: 30955228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
    Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Ahmed N; Jawad N; Jafri S; Raja W
    Cureus; 2020 Jan; 12(1):e6613. PubMed ID: 32064193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score.
    Echevarria C; Steer J; Bourke SC
    Thorax; 2019 Oct; 74(10):941-946. PubMed ID: 31387892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the Chronic Obstructive Pulmonary Disease (COPD) Puzzle: Investigating the Significance of Exacerbation Scores in Triage Decision-Making.
    Allena N; Khanal S; Jog A; Duran MJ; Paulino S; Bojja S; Soliman M
    Cureus; 2023 Jul; 15(7):e41975. PubMed ID: 37593292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
    Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Cen J; Ma H; Chen Z; Weng L; Deng Z
    Respir Med; 2019 Mar; 148():43-48. PubMed ID: 30827473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting Borg score as a predictor of safe discharge of chronic obstructive pulmonary disease from the emergency department observation unit.
    Sengupta R; Loftus TM; Doers M; Jandarov RA; Phillips M; Ko J; Panos RJ; Zafar MA
    Acad Emerg Med; 2020 Dec; 27(12):1302-1311. PubMed ID: 32678934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies.
    Shen MH; Qiu GQ; Wu XM; Dong MJ
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4037-4050. PubMed ID: 34156682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.